Study of Oral Topotecan With Bevacizumab for Recurrent Small Cell Lung Cancer

Clinical trial NCT00698516 · COMPLETED

Trial details

NCT number: NCT00698516
Sponsor: GlaxoSmithKline
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Recurrent Small-cell Lung Cancer (SCLC)Lung Cancer, Small Cell

Start date: 2008-07-01
Primary completion: 2010-05-01
Enrollment: 50

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.